Rodger Novak, President at CRISPR Therapeutics AG (CRSP), sold 49,950 shares at $129.46 ($6.4M) on 2021-06-21, disclosed to the SEC on 2021-06-23.
Open-market sale of $6.4M CRSP by President. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $125.58 | 1,171 | $147K | 2.3% |
| 2 | $125.58 | 1,171 | $147K | 2.3% |
| 3 | $126.62 | 881 | $112K | 1.7% |
| 4 | $126.62 | 881 | $112K | 1.7% |
| 5 | $127.71 | 2,969 | $379K | 5.9% |
| 6 | $127.71 | 2,969 |
| $379K |
| 5.9% |
| 7 | $128.76 | 12,630 | $1.6M | 25.3% |
| 8 | $128.76 | 12,630 | $1.6M | 25.3% |
| 9 | $129.46 | 7,299 | $945K | 14.7% |
| 10 | $129.46 | 7,299 | $945K | 14.7% |
| 11 | $130.27 | 50 | $7K | 0.1% |
| Total | $128.62 avg | 49,950 | $6.4M | 100% |
| Filing → |
| CRSP | SELL | 2020-12-02 | $6.3M | — | Filing → |
| CRSP | SELL | 2020-10-13 | $2.5M | — | Filing → |
| CRSP | SELL | 2020-09-03 | $4.6M | — | Filing → |